Blockade of RAGE suppresses periodontitis-associated bone loss in diabetic mice

Journal of Clinical Investigation

Volumn 105, Issue 8, 2000, Pages 1117-1124

  Lalla, Evanthia ^a   Lamster, Ira B ^a   Feit, Michael ^a   Huang, Linda ^a   Spessot, Alexandra ^a   Qu, Wu ^b   Kislinger, Thomas ^b   Lu, Yan ^b   Stern, David M ^b   Schmidt, Ann Marie ^b  

^a Columbia University ^*  (United States)

^b The New York Presbyterian Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCATION END PRODUCT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE ATROPHY; CYTOKINE PRODUCTION; DIABETES MELLITUS; INFLAMMATION; MALE; MOUSE; NONHUMAN; PATHOGENESIS; PERIODONTITIS; PORPHYROMONAS GINGIVALIS; PRIORITY JOURNAL;

EID: 0034102284     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI8942     Document Type: Article

References (55)

1. Cianciola, L., Park, B., Bruck, E., Mosorich, L., and Genco, R.J. 1982. Prevalence of periodontal disease in insulin-dependent diabetes mellitus. J. Am. Dent. Assoc. 104:653-660.
2. Shlossman, M., Knowler, W.C., Pettitt, D.J., and Genco, R.J. 1990. Type 2 diabetes mellitus and penodontal disease. J. Am. Dent. Assoc. 121:531-536.
3. Löe, H. 1993 Penodontal disease. The sixth complication of diaberes mellitus. Diabetes Care. 16:329-334.
4. Manouchehr-Pour, M., Spagnuolo, P.J., Rodman, H.M., and Bissada, N.F. 1981. Comparison of neutrophil chemoractic response in diabetic patients with mild and severe penodontal disease. J. Periodontol. 52:410-414.
5. McMullen, J.A., Van Dyke, T.E., Horoszevicz, H.U., and Genco, R.J. 1981. Neutrophil chemotaxis in individuals with advanced periodontal disease and a genetic predisposition to diabetes mellitus. J. Periodontol. 52:167-173.
6. Ramamurthy, N.S., and Golub, L.M. 1983. Diaberes increases collagenase activity in extracts of rat gingiva and skin. J. Periodontol Res. 18:23-30.
7. Sasaki, T., Ramamurthy, N.S., Yu, Z., and Golub, L.M. 1992. Tetracycline administration increases protein (presumably procollagen) synthesis and secretion in periodontal ligament fibroblasts of streptozotocin-induced diabetic rats. J. Periodontal Res. 27:631-639.
8. 2 shows stable interindividual differences. Scand. J. Immunol. 27:705-716.
9. Salv,. G.E., et al. 1997. Monocytic TNF-α secretion patterns in IDDM patients with penodontal diseases. J. Clin. Periodontol. 24:8-16.
10. Salvi, G.E., et al. 1997. Inflammatory mediator response as a potential risk marker for periodontal diseases in insulin dependent diaberes mellitus patients. J. Periodontal Res. 68:127-135.
11. Brownlee, M., Cerami, A., and Vlassara, H. 1988. Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. N. Engl. J. Med. 318: 1315-1320.
12. Bucala, R., et al. 1994. Modification of low density lipoprotein by AGEs contributes to the dyslipidemia of diabetes and renal insufficiency. Proc. Natl. Acad. Sci. USA. 27:9441-9445.
13. Ruderman, N., Williamson, J., and Brownlee, M. 1992. Glucose and diabetic vascular disease. FASEB J. 6:2905-2914.
14. Schmidt, A.M., et al. 1992. Isolation and characterization of binding proteins for advanced glycosylation end products from lung tissue which are present on the endothelial cell surface. J. Biol. Chem. 267:14987-14997.
15. Neeper, M., et al. 1992. Cloning and expression of RAGE: a cell surface receptor for advanced glycosylation end products of proteins. J. Biol. Chem 267:14998-15004.
16. Brett, J., et al. 1993. Tissue distribution of the receptor for advanced glycation end products (RAGE): expression in smooth muscle, cardiac myocytes, and neural tissue in addition to the vasculature. Am. J. Pathol. 143:1699-1712.
17. Schmidt, A.M., Yan, S.D., and Stern, D. 1995. The dark side of glucose (News and Views). Nat. Med. 1:1002-1004.
18. 2-Microglobulin modified with advanced glycation end products modulates collagen synrhesis by human fibroblasts. Kidney Int. 53:1365-1373.
19. Schmidt, A.M., Yan, S.D., Wautier, J.L., and Stern, D. 1999. Activation of recepror for advanced glycation end products: a mechanism for chronic vascular dysfunction in diaberic vasculopathy and atherosclerosis. Circ. Res. 84:489-497.
20. Seppala, B., Sorsa, T., and Ainamo, J. 1997. Morphometric analysis of cellular and vascular changes in gingival connective tissue in long-term insulin-dependent diabetes. J. Periodontol. 68:1237-1245.
21. Wautier, J.L., et al. 1996. Receptor-mediated endothelial cell dysfunction in diabetic vasculopathy: soluble receptor for advanced glycation end products blocks hyperpermeability. J. Clin. Invest. 97:238-243.
22. Park, L., et al. 1998. Suppression of accelerated diabetic atherosclerosis by soluble recepror for AGE (sRAGE). Nat. Med. 4:1025-1031.
23. Hofmann, M.A.. et al. 1999 RAGE: mediates a novel proinflammatory axis: a central cell surface receptor for S 100/calgranulin polypeptides. Cell. 97:889-901.
24. Schafer, B.W., and Heinzmann, C.W. 1996. The S100 family of EF-hand calcium-binding proteins: functions and pathology. Trends Bichem. Sci. 21:134-140.
25. Zimmer, D.B., Cornwall, E.H., Landar, A., and Song, W. 1995. The S100 protein family: history, function, and expression. Brain Res. Bull. 37:417-429.
26. Lalla, K., Lamster, I.B., Feit, M., Huang, L., and Schmidt, A.M. 1998. A murine model of accelerated periodontal disease in diabetes. J. Periodontal Res. 33:387-399.
27. Evans, R.T., et al. 1992 Periodontopathic potential of two strains of Porphyromonas gingivalis in gnotobiotic rats. Arch. Oral. Biol. 3:813-819.
28. Chang, K.M., et al. 1994. Tetracyclines inhibit Porphyromonas gingivalis-induced alveolar bone loss in rats by a non-antimicrobial mechanism. J. Periodontal Res. 29:242-249.
29. Kislinger, T., et al. 1999,. N(epsilon)-(carboxymethyl)lysine adducts of proteins are ligands for receptor for advanced glycation end products that activate cell signaling pathways and modulate gene expression. J. Biol. Chem. 274:31740-31749.
30. Lamster, I.B., and Novak, M.J. 1992. Host mediators in gingival crevicular fluid: implications tor the pathogenesis of periodontal disease. Crit. Rev.Oral Biol. Med. 3:31-60.
31. Stashenko, P., Jandinski, J.J., Fujiyoshi, P., Rynar, J., and Socransky, S.S. 1991. Tissue levels of bone resorptive cytokines in periodontal disease. J. Periodontol. 62:504-509.
32. Reynolds, J.J., and Meikle, M.C. 1997. Mechanisms of connective tissue matrix destruction in periodontitis. Periodontol. 2000. 14:144-157.
33. Adehanjo, O.A., et al. 1998. Mode of action of IL-6 on mature osteoclasts. Novel interactions with extracellular calcium-sensing in the regulation of osteoclastic bone resorption. J. Cell Biol 142:1347-1356.
34. Manolagas, S.C. 1998. The role of IL-6 type cytokines and their receptors in bone. Ann NY Acad. Sci. 840:194-204.
35. Li, J., and Schmidt, A.M. 1997. Characterization and functional analysis of the promoter of RAGE, the receptor for advanced glycation endproducts. J. Biol. Chem. 272:16498-16506.
36. Pickup, J.C., and Crook, M.A. 1998. Is type 2 diabetes mellitus a disease of the innate immune system? Diabetologia. 41:1241-1248.
37. Schalkwijk, C.G., et al. 1999. Plasma concentration of C-reactive protein is increased in type 1 diabetic patients without clinical macroangiopathy and correlates with markers of enciothelial dysfunction: evidence for chronic inflammation. Diabetolpgia. 42:351-357.
38. Jensen, T., Borch-Johnson, K., Kofoed-Enevoldsen, A., and Decker, T. 1987. Coronary heart disease in young type I diabetic patients with and without diabetic nephropathy: incidence and risk factors. Diabetologia. 30:144-148.
39. Messent, J., et al. 1992. Prognostic significance of microalbuminuria in insulin-dependent diabetes mellitus: a twenty-three year follow-up study. Kidney Int. 41:836-839.
40. Beck J.D., Offenbacher, S., Williams, R., Gibbs, P., and Garcia, R. 1998. Periodontitis: a risk factor for coronary heart disease? Ann. Periodontol. 3:127-141.
41. Meyer, D.H., and Fives-Taylor, P.M. 1998. Oral pathogens: from dental plaque to cardiac disease. Cure. Opin. Microbiol. 1:88-95.
42. Morrison, H.I., Ellison, L.F., and Taylor, G.W. 1999. Periodontal disease and risk of fatal coronary heart and cerebrovascuhr diseases. J. Cardiovasc. Risk. 6:7-11.
43. Destefano, F., Anda, R.F., Kahn, H.S., Williamson, D.F., and Russell, C.M. 1993. Dental disease and risk of coronary heart disease and mortality. BMJ 306:688-691.
44. Ross, R. 1999. Atherosclerosis: an inflammatory disease. N. Engl. J. Med. 340:115-126.
45. Uusitupa, M.I., Niskanen, L.K., Siitonen, O., Voutilainen, E., and Porala, K. 1990. Five-year incidence of atherosclerotic vascular disease in relation to general risk factors, insulin level, and abnormalities in lipaprotein composition in non-insulin-dependent diabetic and non-diabetic subjects. Circulation. 82:27-36.
46. Manson, J.E., et al. 1991. A prospective study of maturity-onset diabetes mellitus and risk of coronary heart disease and stroke in women. Arch. Intern. Med. 151:1141-1147.
47. Grossi, S.G., et al. 1997. Treatment of penodontal disease in diabetics reduces glycated hemoglobin. J. Periodontol. 68:713-719.
48. World Workshop in Periodontics. 1996. Consensus report non-surgical pocket therapy: mechanical, pharmacotherapeutics, and dental occlusion. Ann. Periodontol. 2:581-588.
49. Williams, R.C., et al. 1989. Altering the progression of human alveolar bone loss with the non-steroidal anti-inflammatory drug flurbiprofen. J. Periodontol. 9:485-490.
50. Kornman, K.S., Blodgett, R.F., Brunsvold, M., and Holt, S.C. 1990. Effects of topical applications of medofenamic acid and ibuprofen on bone loss, subgingival microobiota and gingival PMN response in the primate Macaca fascicularis. J. Periodontal Res. 25:300-307.
51. Golub, L.M., et al. 1998. Terracyclines inhibit connective tissue breakdown by multiple non-antimicrobial mechanisms. Adv. Dent. Res. 12:12-26.
52. Noguchi, K., et al. 1996. Prostaglandin production via induction of cyclooxygenase-2 by human gingival fibroblasts stimulated with lipopolysacharides. Inflammation. 5:555-568.
53. Craig, R.G., et al. 1998. A chemically modified tetracycline inhibits streptoxotocin-induced diabetic depression of skin collagen synthesis and steady-state type I procollagen mRNA. Biochem. Biophys. Acta. 1402:250-260.
54. Golub, L.M., et al. 1983. Minocycline reduces gingival collagenolytic activity during diabetes. J. Periodontal Res. 18:516-526.
55. Graves, D.T., et al. 1998. Interleukin-1 and rumor necrosis factor antagonists inhibit the progression of inflammatory cell infiltration toward alveolar bone in experimental periodontitis. J. Periodontol. 69:1419-1425.